Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice.

PubWeight™: 1.84‹?› | Rank: Top 3%

🔗 View Article (PMC 1942055)

Published in Clin Exp Immunol on November 01, 2006

Authors

R Ito1, M Shin-Ya, T Kishida, A Urano, R Takada, J Sakagami, J Imanishi, M Kita, Y Ueda, Y Iwakura, K Kataoka, T Okanoue, O Mazda

Author Affiliations

1: Department of Microbiology, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Articles citing this

Chronic inflammation and cytokines in the tumor microenvironment. J Immunol Res (2014) 2.51

Interferon-gamma regulates intestinal epithelial homeostasis through converging beta-catenin signaling pathways. Immunity (2010) 2.39

TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation. Gastroenterology (2008) 2.06

Peptidoglycan recognition proteins protect mice from experimental colitis by promoting normal gut flora and preventing induction of interferon-gamma. Cell Host Microbe (2010) 1.85

Apple polyphenols require T cells to ameliorate dextran sulfate sodium-induced colitis and dampen proinflammatory cytokine expression. J Leukoc Biol (2011) 1.48

A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis. Am J Physiol Gastrointest Liver Physiol (2009) 1.39

The regulation of inflammation by interferons and their STATs. JAKSTAT (2013) 1.35

Colonic eosinophilic inflammation in experimental colitis is mediated by Ly6C(high) CCR2(+) inflammatory monocyte/macrophage-derived CCL11. J Immunol (2011) 1.33

NF-kappaB-dependent synergistic regulation of CXCL10 gene expression by IL-1beta and IFN-gamma in human intestinal epithelial cell lines. Int J Colorectal Dis (2007) 1.16

ATF3 regulates MCMV infection in mice by modulating IFN-gamma expression in natural killer cells. Proc Natl Acad Sci U S A (2008) 1.13

Critical role of Bcl11b in suppressor function of T regulatory cells and prevention of inflammatory bowel disease. J Exp Med (2011) 1.13

Nitrated oleic acid up-regulates PPARgamma and attenuates experimental inflammatory bowel disease. Free Radic Biol Med (2009) 1.04

Distinct roles of helper T-cell subsets in a systemic autoimmune disease. Blood (2008) 1.04

Lineage-specific T-cell responses to cancer mucosa antigen oppose systemic metastases without mucosal inflammatory disease. Cancer Res (2009) 1.01

Tumor necrosis factor-{alpha} downregulates intestinal NHE8 expression by reducing basal promoter activity. Am J Physiol Cell Physiol (2008) 1.00

Impact of lipoteichoic acid modification on the performance of the probiotic Lactobacillus rhamnosus GG in experimental colitis. Clin Exp Immunol (2010) 0.96

Protective role of macrophage-derived ceruloplasmin in inflammatory bowel disease. Gut (2012) 0.94

Impaired self-renewal and increased colitis and dysplastic lesions in colonic mucosa of AKR1B8-deficient mice. Clin Cancer Res (2014) 0.94

Ablation of gly96/immediate early gene-X1 (gly96/iex-1) aggravates DSS-induced colitis in mice: role for gly96/iex-1 in the regulation of NF-kappaB. Inflamm Bowel Dis (2010) 0.93

STAT2 contributes to promotion of colorectal and skin carcinogenesis. Cancer Prev Res (Phila) (2010) 0.92

Interferon gamma-dependent intestinal pathology contributes to the lethality in bacterial superantigen-induced toxic shock syndrome. PLoS One (2011) 0.92

P-selectin glycoprotein ligand-1 is needed for sequential recruitment of T-helper 1 (Th1) and local generation of Th17 T cells in dextran sodium sulfate (DSS) colitis. Inflamm Bowel Dis (2012) 0.92

Production of interferon-gamma by activated T-cell receptor-alphabeta CD8alphabeta intestinal intraepithelial lymphocytes is required and sufficient for disruption of the intestinal barrier integrity. Immunology (2009) 0.90

Tumor necrosis factor-alpha impairs intestinal phosphate absorption in colitis. Am J Physiol Gastrointest Liver Physiol (2009) 0.90

Hyaluronan-mediated leukocyte adhesion and dextran sulfate sodium-induced colitis are attenuated in the absence of signal transducer and activator of transcription 1. Am J Pathol (2008) 0.90

Intestinal CD103(+)CD11b(-) dendritic cells restrain colitis via IFN-γ-induced anti-inflammatory response in epithelial cells. Mucosal Immunol (2015) 0.90

The atypical chemokine receptor D6 contributes to the development of experimental colitis. J Immunol (2009) 0.89

Inflammatory Bowel Disease: An Overview of Immune Mechanisms and Biological Treatments. Mediators Inflamm (2015) 0.89

Effects of alanyl-glutamine dipeptide on the expression of colon-inflammatory mediators during the recovery phase of colitis induced by dextran sulfate sodium. Eur J Nutr (2012) 0.87

Glabridin, a functional compound of liquorice, attenuates colonic inflammation in mice with dextran sulphate sodium-induced colitis. Clin Exp Immunol (2007) 0.86

IFN-γ attenuates hypoxia-inducible factor (HIF) activity in intestinal epithelial cells through transcriptional repression of HIF-1β. J Immunol (2011) 0.86

Protective role of Akt2 in Salmonella enterica serovar typhimurium-induced gastroenterocolitis. Infect Immun (2011) 0.86

Interferon-γ alters downstream signaling originating from epidermal growth factor receptor in intestinal epithelial cells: functional consequences for ion transport. J Biol Chem (2011) 0.85

Loss of Ca-mediated ion transport during colitis correlates with reduced ion transport responses to a Ca-activated K channel opener. Br J Pharmacol (2009) 0.85

NADH oxidase-dependent CD39 expression by CD8(+) T cells modulates interferon gamma responses via generation of adenosine. Nat Commun (2015) 0.83

IFN-γ-mediated induction of an apical IL-10 receptor on polarized intestinal epithelia. J Immunol (2013) 0.82

Intestinal Epithelial Cell Tyrosine Kinase 2 Transduces IL-22 Signals To Protect from Acute Colitis. J Immunol (2015) 0.82

Antibiotics increase gut metabolism and antioxidant proteins and decrease acute phase response and necrotizing enterocolitis in preterm neonates. PLoS One (2012) 0.81

Differential dose effects of recombinant IL-25 on the development of dextran sulfate sodium-induced colitis. Inflamm Res (2010) 0.81

Suppression of Th1 cytokine production by a peptide derived from C4b. Inflamm Res (2013) 0.81

Gallic acid attenuates dextran sulfate sodium-induced experimental colitis in BALB/c mice. Drug Des Devel Ther (2015) 0.81

Deletion of cationic amino acid transporter 2 exacerbates dextran sulfate sodium colitis and leads to an IL-17-predominant T cell response. Am J Physiol Gastrointest Liver Physiol (2013) 0.81

Therapeutic effects of mouse bone marrow-derived clonal mesenchymal stem cells in a mouse model of inflammatory bowel disease. J Clin Biochem Nutr (2015) 0.81

Noncanonical Effects of IRF9 in Intestinal Inflammation: More than Type I and Type III Interferons. Mol Cell Biol (2015) 0.80

Reduced surface expression of epithelial E-cadherin evoked by interferon-gamma is Fyn kinase-dependent. PLoS One (2012) 0.80

Homologous high-throughput expression and purification of highly conserved E coli proteins. Microb Cell Fact (2007) 0.79

IFN-γ Prevents Adenosine Receptor (A2bR) Upregulation To Sustain the Macrophage Activation Response. J Immunol (2015) 0.78

Preventive and therapeutic effects of nitrite supplementation in experimental inflammatory bowel disease. Redox Biol (2013) 0.78

Altered gp130 signalling ameliorates experimental colitis via myeloid cell-specific STAT3 activation and myeloid-derived suppressor cells. Sci Rep (2016) 0.78

T Cell-Associated Cytokines in the Pathogenesis of Sjögren's Syndrome. J Clin Cell Immunol (2013) 0.78

Somatostatin inhibits the production of interferon-γ by intestinal epithelial cells during intestinal ischemia-reperfusion in macaques. Dig Dis Sci (2014) 0.77

Genetic risk factors for serious infections in inflammatory bowel diseases. Scand J Gastroenterol (2017) 0.77

Nod1 Limits Colitis-Associated Tumorigenesis by Regulating IFN-γ Production. J Immunol (2016) 0.76

Protective effects of heat-killed Lactococcus lactis subsp. lactis BF3, isolated from the intestine of chum salmon, in a murine model of DSS-induced inflammatory bowel disease. Biosci Microbiota Food Health (2016) 0.75

Angelica acutiloba Kitagawa Extract Attenuates DSS-Induced Murine Colitis. Mediators Inflamm (2016) 0.75

Attenuation of antigen-specific T helper 1 immunity by Neolitsea hiiranensis and its derived terpenoids. PeerJ (2016) 0.75

Role of interferon-γ and inflammatory monocytes in driving colonic inflammation during acute Clostridium difficile infection in mice. Immunology (2017) 0.75

Intestinal mononuclear cells primed by systemic interleukin-12 display long-term ability to aggravate colitis in mice. Immunology (2016) 0.75

G2A Signaling Dampens Colitic Inflammation via Production of IFN-γ. J Immunol (2016) 0.75

Intestinal inflammation without weight loss decreases bone density and growth. Am J Physiol Regul Integr Comp Physiol (2016) 0.75

The L-Arginine Transporter Solute Carrier Family 7 Member 2 Mediates the Immunopathogenesis of Attaching and Effacing Bacteria. PLoS Pathog (2016) 0.75

Novel benzoxazole derivatives DCPAB and HPAB attenuate Th1 cell-mediated inflammation through T-bet suppression. Sci Rep (2017) 0.75

Context-dependent regulation of Th17-associated genes and IFNγ expression by the transcription factor NFAT5. Immunol Cell Biol (2016) 0.75

Effect of Cyperus Rotundus on Cytokine Gene Expression in Experimental Inflammatory Bowel Disease. Iran J Med Sci (2016) 0.75

B cells are involved in the modulation of pathogenic gut immune response in food-allergic enteropathy. Clin Exp Immunol (2008) 0.75

K+ Channel Inhibition Differentially Regulates Migration of Intestinal Epithelial Cells in Inflamed vs. Non-Inflamed Conditions in a PI3K/Akt-Mediated Manner. PLoS One (2016) 0.75

Articles cited by this

A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology (1990) 11.22

Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest (1993) 10.09

Chemokines. Blood (1997) 9.80

Chemokines and leukocyte traffic. Nature (1998) 9.79

Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity (1994) 9.63

Experimental models of inflammatory bowel disease. Gastroenterology (1995) 6.28

The molecular cell biology of interferon-gamma and its receptor. Annu Rev Immunol (1993) 5.88

Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol (1998) 5.77

Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology (1994) 4.57

Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis (2006) 4.29

Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers. J Clin Invest (1989) 4.28

Mig and IP-10: CXC chemokines that target lymphocytes. J Leukoc Biol (1997) 4.27

Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science (1996) 3.32

Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest (1999) 3.21

Interleukin-2- and interferon-gamma-secreting T cells in normal and diseased human intestinal mucosa. Immunology (1993) 3.20

CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc Natl Acad Sci U S A (1999) 3.07

Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation. Am J Physiol Gastrointest Liver Physiol (2005) 2.80

Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation. J Pathol (2001) 2.57

Cytokines in inflammatory bowel disease. World J Surg (1998) 2.30

Suppression of concanavalin A-induced hepatitis in IFN-gamma(-/-) mice, but not in TNF-alpha(-/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes. J Immunol (1997) 2.22

Spontaneous release of interferon gamma by intestinal lamina propria lymphocytes in Crohn's disease. Kinetics of in vitro response to interferon gamma inducers. Gut (1991) 2.21

Changes in colonic mucosal permeability in mouse colitis induced with dextran sulfate sodium. Exp Anim (1999) 2.20

Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency. Digestion (2000) 2.09

Monocyte-chemoattractant protein 1 gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa. Gastroenterology (1995) 2.07

Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice. Clin Exp Immunol (1999) 1.97

Regulated production of interferon-inducible T-cell chemoattractants by human intestinal epithelial cells. Gastroenterology (2001) 1.86

CXCR3 and CCR5 ligands in rheumatoid arthritis synovium. Clin Immunol (2001) 1.85

Production of monocyte chemoattractant protein-1 by inflamed synovial tissue and cultured synoviocytes. J Immunol (1992) 1.72

Detection of a gamma interferon-induced protein IP-10 in psoriatic plaques. J Exp Med (1988) 1.67

Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection. Am J Pathol (2001) 1.63

Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis. Am J Pathol (1999) 1.62

Effects of dextran sulphate sodium on intestinal epithelial cells and intestinal lymphocytes. Gut (1996) 1.60

Involvement of the IP-10 chemokine in sarcoid granulomatous reactions. J Immunol (1998) 1.56

Differential in situ expression of the genes encoding the chemokines MCP-1 and RANTES in human inflammatory bowel disease. J Pathol (1996) 1.52

A pivotal involvement of IFN-gamma in the pathogenesis of acetaminophen-induced acute liver injury. FASEB J (2002) 1.51

Cytokine production in patients with inflammatory bowel disease. Gut (1992) 1.50

Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection. Circulation (2001) 1.42

Enhanced expression and production of monocyte chemoattractant protein-1 in inflammatory bowel disease mucosa. J Leukoc Biol (1996) 1.39

Sequential cytokine dynamics in chronic rejection of rat renal allografts: roles for cytokines RANTES and MCP-1. Proc Natl Acad Sci U S A (1995) 1.34

Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis. Clin Exp Immunol (2003) 1.31

Essential involvement of IFN-gamma in Clostridium difficile toxin A-induced enteritis. J Immunol (2004) 1.28

Interferon gamma production by human intestinal mucosal mononuclear cells. Decreased levels in inflammatory bowel disease. Dig Dis Sci (1988) 1.24

Changes in bacterial phagocytosis of macrophages in experimental ulcerative colitis. Digestion (1995) 1.22

Characterization of chemokines and chemokine receptors in two murine models of inflammatory bowel disease: IL-10-/- mice and Rag-2-/- mice reconstituted with CD4+CD45RBhigh T cells. Eur J Immunol (2001) 1.20

The central role of chemokines (chemotactic cytokines) in the immunopathogenesis of ulcerative colitis and Crohn's disease. Inflamm Bowel Dis (1998) 1.16

Monocyte chemoattractant protein 1 (MCP-1) expression occurs in toxic rat liver injury and human liver disease. J Leukoc Biol (1994) 1.15

MCP-1 mRNA expression in basal keratinocytes of psoriatic lesions. J Invest Dermatol (1993) 1.15

Hapten-induced colitis associated with maintained Th1 and inflammatory responses in IFN-gamma receptor-deficient mice. Eur J Immunol (2000) 1.12

An orally active matrix metalloproteinase inhibitor, ONO-4817, reduces dextran sulfate sodium-induced colitis in mice. Inflamm Res (2004) 1.12

Alleviation of lipopolysaccharide-induced acute liver injury in Propionibacterium acnes-primed IFN-gamma-deficient mice by a concomitant reduction of TNF-alpha, IL-12, and IL-18 production. J Immunol (1999) 1.10

Interleukin-12 induced interferon-gamma increases inflammation in acute dextran sulfate sodium induced colitis in mice. Eur Cytokine Netw (2000) 1.10

Interferon gamma induces differential upregulation of alpha and beta chemokine secretion in colonic epithelial cell lines. Gut (1998) 1.06

Experimental colitis induced by dextran sulphate sodium in mice: beneficial effects of sulphasalazine and olsalazine. Aliment Pharmacol Ther (1998) 1.05

Evidence for the critical role of interleukin-12 but not interferon-gamma in the pathogenesis of experimental colitis in mice. J Gastroenterol Hepatol (2003) 1.02

IP-10 and Mig production by glomerular cells in human proliferative glomerulonephritis and regulation by nitric oxide. J Am Soc Nephrol (2002) 0.98

Interferon expression in Crohn's disease patients: increased interferon-gamma and -alpha mRNA in the intestinal lamina propria mononuclear cells. J Interferon Res (1994) 0.98

Mouse models of inflammatory bowel disease. Curr Opin Drug Discov Devel (2006) 0.97

The significance of interferon-gamma-triggered internalization of tight-junction proteins in inflammatory bowel disease. Sci STKE (2006) 0.96

The role of interferon gamma in the pathogenesis of Crohn's disease. Gastroenterol Jpn (1992) 0.94

The proportion of Th1 cells, which prevail in gut mucosa, is decreased in inflammatory bowel syndrome. Clin Exp Immunol (2001) 0.93

Enhanced interferon-gamma production and B7-2 expression in isolated intestinal mononuclear cells from patients with Crohn's disease. J Gastroenterol (1995) 0.88

Cytokine production in whole blood cell cultures of patients with Crohn's disease and ulcerative colitis. J Clin Lab Anal (1994) 0.86

Chemokines in inflammatory bowel disease. J Clin Pathol (2005) 0.85

Anti-interferon-gamma antibodies in the treatment of autoimmune diseases. Curr Opin Mol Ther (2003) 0.84

Articles by these authors

Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet (1997) 6.83

Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene (2006) 6.61

Isolation and characterization of acid phosphatase mutants in Saccharomyces cerevisiae. J Bacteriol (1973) 5.24

Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery (1988) 5.03

Studies on protein folding, unfolding and fluctuations by computer simulation. I. The effect of specific amino acid sequence represented by specific inter-unit interactions. Int J Pept Protein Res (1975) 4.49

Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. Nat Nanotechnol (2011) 4.22

Regulation of transcription by dimerization of erythroid factor NF-E2 p45 with small Maf proteins. Nature (1994) 4.20

Production of mice deficient in genes for interleukin (IL)-1alpha, IL-1beta, IL-1alpha/beta, and IL-1 receptor antagonist shows that IL-1beta is crucial in turpentine-induced fever development and glucocorticoid secretion. J Exp Med (1998) 4.17

Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J Exp Med (2000) 4.06

Prevalence of serum and salivary antibodies to HTLV-1 in Sjögren's syndrome. Lancet (1994) 3.83

Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res (1994) 3.62

Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids. Transplant Proc (1987) 3.55

Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains. Gut (1997) 3.39

Renal transplantation in baboons under FK 506. Surgery (1989) 3.17

Biosynthesis of RNA polymerase in Escherichia coli. I. Control of RNA polymerase content at various growth rates. Mol Gen Genet (1974) 3.15

Orthotopic liver transplantation in dogs receiving FK-506. Transplant Proc (1987) 3.11

Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa. Gastroenterology (1996) 3.00

Activating mutations for the met tyrosine kinase receptor in human cancer. Proc Natl Acad Sci U S A (1997) 2.92

Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype. Hum Mutat (1995) 2.91

A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Japan HBV Genotype Research Group. Hepatology (2001) 2.80

Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan. Hum Mutat (1996) 2.80

Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nat Med (2001) 2.74

Isolation and characterization of recessive, constitutive mutations for repressible acid phosphatase synthesis in Saccharomyces cerevisiae. J Bacteriol (1975) 2.71

Postexposure prophylaxis of varicella in family contact by oral acyclovir. Pediatrics (1993) 2.67

Molecular cloning of the von Hippel-Lindau tumor suppressor gene and its role in renal carcinoma. Biochim Biophys Acta (1996) 2.64

Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan. Hepatology (2001) 2.62

The p250 subunit of native TATA box-binding factor TFIID is the cell-cycle regulatory protein CCG1. Nature (1993) 2.50

Growth factors: importance in wound healing and maintenance of transparency of the cornea. Prog Retin Eye Res (2000) 2.48

Caspase 1-independent IL-1beta release and inflammation induced by the apoptosis inducer Fas ligand. Nat Med (1998) 2.47

Requirement of 19K form of Sonic hedgehog for induction of distinct ventral cell types in CNS explants. Nature (1995) 2.46

Relationship of vacA genotypes of Helicobacter pylori to cagA status, cytotoxin production, and clinical outcome. Helicobacter (1998) 2.39

RNA packaging signal of human immunodeficiency virus type 1. Virology (1992) 2.38

Mutually exclusive expression of odorant receptor transgenes. Nat Neurosci (2000) 2.36

Cytoskeletal reorganization by soluble Wnt-3a protein signalling. Genes Cells (1998) 2.33

Enhanced proliferative potential in culture of cells from p53-deficient mice. Oncogene (1993) 2.25

v-maf, a viral oncogene that encodes a "leucine zipper" motif. Proc Natl Acad Sci U S A (1989) 2.24

Suppression of concanavalin A-induced hepatitis in IFN-gamma(-/-) mice, but not in TNF-alpha(-/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes. J Immunol (1997) 2.22

Role of IL-1alpha and IL-1beta in ischemic brain damage. J Neurosci (2001) 2.20

Dynamics of hepatitis C viremia following interferon-alpha administration. J Infect Dis (1998) 2.18

Noninvasive assessment of coronary flow velocity and coronary flow velocity reserve in the left anterior descending coronary artery by Doppler echocardiography: comparison with invasive technique. J Am Coll Cardiol (1998) 2.14

Role of gamma interferon in Helicobacter pylori-induced gastric inflammatory responses in a mouse model. Infect Immun (1999) 2.14

Expression of cytokine mRNA in gastric mucosa with Helicobacter pylori infection. Scand J Gastroenterol (1995) 2.12

Relativistic jet activity from the tidal disruption of a star by a massive black hole. Nature (2011) 2.12

Induction of pulmonary indoleamine 2,3-dioxygenase by interferon. Proc Natl Acad Sci U S A (1981) 2.10

Chemokines in the gastric mucosa in Helicobacter pylori infection. Gut (1998) 2.07

Outer dense fiber 2 is a widespread centrosome scaffold component preferentially associated with mother centrioles: its identification from isolated centrosomes. Mol Biol Cell (2001) 2.04

Protective role of interleukin-1 in mycobacterial infection in IL-1 alpha/beta double-knockout mice. Lab Invest (2000) 1.92

Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-gamma production from activated B cells. Proc Natl Acad Sci U S A (1997) 1.92

A cytoplasmic RNA vector derived from nontransmissible Sendai virus with efficient gene transfer and expression. J Virol (2000) 1.92

Two new members of the maf oncogene family, mafK and mafF, encode nuclear b-Zip proteins lacking putative trans-activator domain. Oncogene (1993) 1.91

The gamete fusion process is defective in eggs of Cd9-deficient mice. Nat Genet (2000) 1.91

NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel. Br J Cancer (2005) 1.87

Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats. Br J Cancer (2005) 1.85

Japanese doctors' attitudes to complementary medicine. Lancet (1999) 1.83

Enhanced external counterpulsation improved myocardial perfusion and coronary flow reserve in patients with chronic stable angina; evaluation by(13)N-ammonia positron emission tomography. Eur Heart J (2001) 1.83

Induction of melanocyte-specific microphthalmia-associated transcription factor by Wnt-3a. J Biol Chem (2000) 1.80

IL-1 enhances T cell-dependent antibody production through induction of CD40 ligand and OX40 on T cells. J Immunol (2001) 1.80

MAFA controls genes implicated in insulin biosynthesis and secretion. Diabetologia (2006) 1.80

v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. A mechanism regulating gene expression independent of that by inflammatory cytokines. J Biol Chem (1993) 1.76

Axin prevents Wnt-3a-induced accumulation of beta-catenin. Oncogene (1999) 1.72

Relation between clinical presentation, Helicobacter pylori density, interleukin 1beta and 8 production, and cagA status. Gut (1999) 1.72

A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis. Eur Respir J (2010) 1.72

Detection of influenza viruses in throat swab by using polymerase chain reaction. Microbiol Immunol (1991) 1.72

Comparison of [(18)F]FDG PET and (201)Tl SPECT in evaluation of pulmonary nodules. J Nucl Med (2001) 1.71

Impaired learning with enhanced hippocampal long-term potentiation in PTPdelta-deficient mice. EMBO J (2000) 1.70

Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. Cancer Res (1991) 1.70

Computational and biological analysis of 680 kb of DNA sequence from the human 5q31 cytokine gene cluster region. Genome Res (1997) 1.69

Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma. Oncogene (2010) 1.69

Defenestration of the sinusoidal endothelial cell in a rat model of cirrhosis. Hepatology (1993) 1.67

Risk factors for cerebral hemorrhage and cerebral infarction in a Japanese rural community. Stroke (1982) 1.67

Transcription factor TFIID induces DNA bending upon binding to the TATA element. Proc Natl Acad Sci U S A (1992) 1.67

Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas. Gut (2005) 1.66

Development of the polymer micelle carrier system for doxorubicin. J Control Release (2001) 1.64

Estimation of coronary flow reserve with the use of dynamic planar and SPECT images of Tc-99m tetrofosmin. J Nucl Cardiol (2001) 1.63

CREB-H: a novel mammalian transcription factor belonging to the CREB/ATF family and functioning via the box-B element with a liver-specific expression. Nucleic Acids Res (2001) 1.62

Successful engraftment following HLA-mismatched cord blood transplantation for patients with anti-HLA Abs. Bone Marrow Transplant (2008) 1.62

Mechanism of renal excretion of AM-715, a new quinolonecarboxylic acid derivative, in rabbits, dogs, and humans. Antimicrob Agents Chemother (1983) 1.59

Distribution of Porphyromonas gingivalis strains with fimA genotypes in periodontitis patients. J Clin Microbiol (1999) 1.58

Critical contribution of IFN-gamma and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of alpha-galactosylceramide. Eur J Immunol (2001) 1.56

Heterogeneity of RNA polymerase in Escherichia coli. I. A new holoenzyme containing a new sigma factor. J Mol Biol (1974) 1.56

Fas-mediated apoptosis in adriamycin-induced cardiomyopathy in rats: In vivo study. Circulation (2000) 1.56

Persistently increased serum concentrations of cardiac troponin t in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes. Circulation (2001) 1.56

Ex vivo whole-embryo culture of caspase-8-deficient embryos normalize their aberrant phenotypes in the developing neural tube and heart. Cell Death Differ (2002) 1.56

Serum levels of soluble tumor necrosis factor receptors and effects of interferon therapy in patients with chronic hepatitis C virus infection. Am J Gastroenterol (1999) 1.54

Selective coactivation of estrogen-dependent transcription by CITED1 CBP/p300-binding protein. Genes Dev (2001) 1.53

Cavitary lung cancer with an aspergilloma-like shadow. Lung Cancer (1999) 1.53

Treadmill training with body weight support: its effect on Parkinson's disease. Arch Phys Med Rehabil (2000) 1.53

Long-circulating poly(ethylene glycol)-poly(D,L-lactide) block copolymer micelles with modulated surface charge. J Control Release (2001) 1.52

Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinoma. Oncogene (2010) 1.52